Sensors, Vol. 20, Pages 3214: Artificial Intelligence in Decision Support Systems for Type 1 Diabetes

Sensors, Vol. 20, Pages 3214: Artificial Intelligence in Decision Support Systems for Type 1 Diabetes Sensors doi: 10.3390/s20113214 Authors: Tyler Jacobs Type 1 diabetes (T1D) is a chronic health condition resulting from pancreatic beta cell dysfunction and insulin depletion. While automated insulin delivery systems are now available, many people choose to manage insulin delivery manually through insulin pumps or through multiple daily injections. Frequent insulin titrations are needed to adequately manage glucose, however, provider adjustments are typically made every several months. Recent automated decision support systems incorporate artificial intelligence algorithms to deliver personalized recommendations regarding insulin doses and daily behaviors. This paper presents a comprehensive review of computational and artificial intelligence-based decision support systems to manage T1D. Articles were obtained from PubMed, IEEE Xplore, and ScienceDirect databases. No time period restrictions were imposed on the search. After removing off-topic articles and duplicates, 562 articles were left to review. Of those articles, we identified 61 articles for comprehensive review based on algorithm evaluation using real-world human data, in silico trials, or clinical studies. We grouped decision support systems into general categories of 1) those which recommend adjustments to insulin and 2) those which predict and help avoid hypoglycemia. We review the artificial intellige...
Source: Sensors - Category: Biotechnology Authors: Tags: Review Source Type: research

Related Links:

CONCLUSION: The preventive strategy is fundamental, since the therapy is complex with poorly validated effectiveness. PMID: 32645129 [PubMed - as supplied by publisher]
Source: Jornal Brasileiro de Nefrologia - Category: Urology & Nephrology Tags: J Bras Nefrol Source Type: research
Conclusions/interpretationAbsolute mortality has fallen, but the relative impact of type 1 diabetes on mortality below 50  years has not improved. There is scope to improve prevention of premature circulatory diseases and DKAoC and to develop more effective strategies for enabling people with type 1 diabetes to avoid clinically significant hyper- or hypoglycaemia.Graphical abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
AbstractDue to primarily sarcopenia and hypoglycemia but also neuropathy, hypotension, analgesics and polypharmacy, there is an increased incidence of falls and hip fractures in both the type 1 and type 2 diabetic patient. Utilization of insulin, hypotensive drugs, analgesics and perhaps canagliflozin further increases the risk. Thiazolidinedione use may increase the risk of osteoporosis and fracture. Prolonged hyperglycemia resulting in cross-linking of collagen and advanced glycosylation end products alter the microarchitecture and increase bone fragility. Higher serum vitamin D levels seem to decrease the incidence of b...
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
paracino Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of type 1 diabetes (T1D). These sensors provide in real-time, every 1–5 min, the current blood glucose concentration and its rate-of-change, two key pieces of information for improving the determination of exogenous insulin administration and the prediction of forthcoming adverse events, such as hypo-/hyper-glycemia. The current research in diabetes technology is putting considerable effort into developing decision support systems for patient use, which automatically analyze the patient’s data collected b...
Source: Sensors - Category: Biotechnology Authors: Tags: Review Source Type: research
The novel coronavirus disease (COVID-19) has been on the rampage ever since its outbreak in December 2019 in Wuhan, China. To date, the disease has affected over 5.3 million people, inflicting more than 342,000 casualties in over 200 nations worldwide [1]. Although the overall mortality rate of COVID-19 ranges from 1.4 to 7.2% [2,3], patients with underlying co-morbidities like diabetes mellitus (DM) tend to have severe disease, acute respiratory distress syndrome (ARDS) and increased mortality [4,5], People with both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are at a high risk of poor outcomes with COVID-19 [6].
Source: Primary Care Diabetes - Category: Primary Care Authors: Tags: Original research Source Type: research
ConclusionsNeither the age of gluten introduction nor the amount of gluten consumed in early childhood is associated with risk of thyroid autoimmunity.
Source: Endocrine - Category: Endocrinology Source Type: research
Premature cardiovascular disease cause excess mortality in type 1 diabetes (T1D). The Steno T1D Risk Engine was developed and validated in northern European countries but its validity in other populations is unknown. We evaluated the performance of the Steno T1D Risk Engine in Italian patients with T1D.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Source Type: research
Dr Richard Pratley discusses results from a study demonstrating that CGM markedly improves outcomes in older individuals with type 1 diabetes.Medscape Diabetes &Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
Authors: Dworakowska D, Grossman AB Abstract COVID-19, which is caused by the single-stranded RNA severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has introduced significant therapeutic dilemmas in several areas. One of these is concern regarding the use of renin-angiotensin system (RAS) inhibitors. Dysfunction of the RAS has been observed in COVID-19 patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type-1 receptor blockers (ARBs), are associated with improved or worse clinical outcomes, remains unclear. RAS inhibitors are currently widel...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
Many youth with type 1 diabetes (T1D) do not achieve hemoglobin A1c (HbA1c) targets. The mean HbA1c of youth in the USA is higher than much of the developed world. Mean HbA1c in other nations has been successfully modified following benchmarking and quality improvement methods. In this review, we describe the novel 4T approach—teamwork, targets, technology, and tight control—to diabetes management in youth with new-onset T1D. In this program, the diabetes care team (physicians, nurse practitioners, certified diabetes educators, dieticians, social workers, psychologists, and exercise physiologists) work closely ...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Biotechnology | Databases & Libraries | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Pancreas | Study